HealthyMe™
Screen for Urinary Tract Infection (UTI) in 2 minutes
The HealthyMe UTI strips are FDA cleared for OTC and CE Marked. The HealthyMe UTI strips are available for worldwide distribution.
Urinary Tract Infection (UTI) reagent strips
Since 2008, ACON Labs has been the leading UTI manufacturer in the US.
The HealthyMe™ brand came to life with the ambition to become the go to brand for Women’s health and Reproductive issues.
The HealthyMe™ Urinary Tract Infection (UTI) reagent strips are highly reliable and easy to use.
Effective Screening
- A simple urine test for the detection of a possible UTI
- Tests for Leucocytes and Nitrites for greater accuracy
- Test similar to those used in doctors’ offices
Ease of Use
- Easy to perform and interpret
- Results in 2 minutes
- Test in the comforts of home
- Nothing extra needed
HealthyMe™
Frequently Asked Questions
What is a urinary tract infection (UTI)?
What causes UTIs?
What are the signs and symptoms of a UTI and how are they diagnosed?
Are UTIs serious?
How common are UTIs in adults?
Recurrent Infections
How are UTIs treated?
Points to Remember
- Most urinary tract infections (UTIs) arise from one type of bacteria, Escherichia coli (E. coli), which normally lives in the bowel.
- Symptoms of a UTI in adults may include the following:
- a frequent and intense urge to urinate.
- a painful, burning feeling in the bladder or urethra during urination.
- feeling tired, shaky, and weak.
- muscle aches.
- abdominal pain.
- only small amounts of urine passed, despite a strong urge to urinate.
- cloudy, dark, or bloody urine or urine that has a foul smell.
- pain in the back or side below the ribs.
- nausea and vomiting.
- Fever may indicate a kidney or prostate infection.
- Because bacteria can be found in the urine of healthy individuals, a UTI is diagnosed based both on symptoms and a laboratory test.
- UTIs are treated with bacteria-fighting medications called antibiotics or antimicrobials.
References
This content is provided as a service of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. The NIDDK translates and disseminates research findings through its clearinghouses and education programs to increase knowledge and understanding about health and disease among patients, health professionals, and the public. Content produced by the NIDDK is carefully reviewed by NIDDK scientists and other experts.The NIDDK would like to thank:
Betsy Foxman, Ph.D., University of Michigan School of Public Health; Anthony Schaeffer, M.D., Northwestern University Medical School
This information is not copyrighted. The NIDDK encourages people to share this content freely.
1Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2006. National health statistics reports; no 8. Hyattsville, MD: National Center for Health Statistics; 2008.
2Griebling TL. Urinary tract infection in women. In: Litwin MS, Saigal CS, eds. Urologic Diseases in America. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, D.C.: GPO; 2007. NIH publication 07–5512:587–619.
3Hooton TM, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 international clinical practice guidelines from the Infectious Diseases Society of America. Clinical Infectious Diseases. 2010;50(5):625–663.
4Tolkoff-Rubin NE, Cotran RS, Rubin RH. Urinary tract infection, pyelonephritis, and reflux nephropathy. In: Brenner BM, ed. Brenner & Rector’s The Kidney. 8th ed. Vol. 2. Philadelphia: Saunders; 2008: 1203–1238.
5Schaeffer AJ. Infections of the urinary tract. In: Walsh PC, Retik AB, Vaughan ED, Wein AJ, eds. Campbell’s Urology. 8th ed. Vol. 1. Philadelphia: Saunders; 2002: 515–602.
6Anderson GG, Palermo JJ, Schilling JD, et al. Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003;301:105–107.
7Stapleton AE, Nudelman E, Clausen H, Hakomori S, Stamm WE. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. Journal of Clinical Investigation. 1992;90;965–972.
8Sharma JB, Aggarwal S, Singhal S, Kumar S, Roy KK. Prevalence of urinary incontinence and other urological problems during pregnancy: a questionnaire based study. Archives of Gynecology and Obstetrics. 2009;279(6):845–851.
Resource Library
Browse our Resources Library for documents available for download.